Search results
Results From The WOW.Com Content Network
Key takeaways: Alyssa Sepulveda tried the usual weight-loss methods, but nothing worked. Her prediabetes diagnosis led her to try semaglutide (Wegovy), and she now injects it once a week. She has lost more than 80 lbs in her first year of using Wegovy, and it has changed her health and her outlook. GoodRx Health.
Wegovy (semaglutide) is a long-term treatment for weight loss. How long you take the drug depends on side effect tolerability and whether it's safe for you.
Wegovy has been shown to be an effective treatment for weight loss. In studies , most people who used Wegovy lost at least 5 percent of their body weight over 68 weeks.
Check your cost and coverage. See your potential weight loss. Determine how much weight you may lose with Wegovy ®. Calculate your potential weight loss. Lowers the risk of major cardiovascular events.
Weight loss of 10 to 15% (or more) is recommended in people with many complications of overweight and obesity (e.g., prediabetes, hypertension, and obstructive sleep apnea). 1,20,21,27 In...
After one year, adults taking Wegovy lost 15% of their weight (35 lb /15.9 kg) on average, compared to a 2.5% weight loss (6 lbs/2.7 kg) in those taking an inactive pill. Overall, after 68 weeks, 83% of adults taking Wegovy lost 5% or more of their weight compared to 31% of adults taking a placebo.
Wegovy® dosing schedule for adults. Start Wegovy ® at a dose of 0.25 mg once a week for your first month. For your second month, you can increase your weekly dose to 0.5 mg. For your third month, you can increase your weekly dose to 1.0 mg. For your fourth month, you can increase your weekly dose to 1.7 mg.
The dosing chart below shows typical Wegovy doses and the drug’s dose schedule for weight loss and weight management. You’ll inject Wegovy once per week.
WegovyTM (semaglutide) injection 2.4 mg is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of ≥30 kg/m2 (obesity) or ≥27 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2...
At the highest dose (15 mg), people using Zepbound lost an average of 21.8 kg (48 lb) or 21% of their body weight, while at the lowest dose (5 mg), people lost an average of 15.5 kg (34 lb) or 15% of their body weight, compared to 3.2 kg (7 lb), or 3%, on placebo.